OTC · SYUP
Anbc, Inc.
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
Loading market information…
OTC · CANQF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CanaQuest Medical Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CanaQuest Medical Corp. focuses on creating health-related products and pharmaceutical solutions by leveraging the properties of hemp, cannabis, and algae oils. The company, which was originally established in 2008, previously operated under the name Algae Dynamics Corp. before adopting its current designation, CanaQuest Medical Corp., in January 2019. Its primary operations are based in Mississauga, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
$0.00-$0.00 (-16.67%)
NxGen Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00+$0.00 (+100.0%)
Genex Pharmaceutical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Longport, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Greenwind Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cotinga Pharmaceuticals Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Urologix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.21% below the high.
